# Short-course Radiotherapy Based TNT Combined With PD-1 Inhibitor for Locally Advanced Rectal Cancer

> **NCT04518280** · PHASE2 · COMPLETED · sponsor: **Fudan University** · enrollment: 130 (actual)

## Conditions studied

- Locally Advanced Rectal Cancer

## Interventions

- **DRUG:** PD-1 antibody
- **DRUG:** Capecitabine
- **DRUG:** Oxaliplatin
- **RADIATION:** Short-course radiotherapy

## Key facts

- **NCT ID:** NCT04518280
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-01
- **Primary completion:** 2023-09-01
- **Final completion:** 2025-01-01
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2025-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04518280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04518280, "Short-course Radiotherapy Based TNT Combined With PD-1 Inhibitor for Locally Advanced Rectal Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04518280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*